Oscar Health (NYSE:OSCR) Reaches New 52-Week Low – Here’s Why

Oscar Health, Inc. (NYSE:OSCR) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $12.85 and last traded at $12.54, with a volume of 1260755 shares traded. The stock had previously closed at $13.76.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target on the stock. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Oscar Health has a consensus rating of “Hold” and a consensus price target of $21.56.

Oscar Health Stock Performance

The company’s 50-day moving average price is $14.76 and its two-hundred day moving average price is $16.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Equities research analysts anticipate that Oscar Health, Inc. will post 0.91 EPS for the current fiscal year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 6,516 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $117,809.28. Following the sale, the insider now directly owns 81,962 shares in the company, valued at $1,481,872.96. This represents a 7.36 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Steven Wolin sold 19,580 shares of the stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the sale, the chief operating officer now owns 102,598 shares in the company, valued at $1,854,971.84. The trade was a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 103,610 shares of company stock valued at $1,847,519. 25.11% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Large investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC grew its stake in Oscar Health by 171.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock worth $89,000 after buying an additional 4,185 shares in the last quarter. KBC Group NV grew its stake in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after buying an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health in the 4th quarter valued at approximately $100,000. Alberta Investment Management Corp acquired a new stake in shares of Oscar Health in the 4th quarter valued at approximately $138,000. Finally, Virtu Financial LLC acquired a new stake in shares of Oscar Health in the 4th quarter valued at approximately $140,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.